Back to Search Start Over

Lack of neo-sensitization to Pen a 1 in patients treated with mite sublingual immunotherapy.

Authors :
Rossi, Renato E.
Monasterolo, Giorgio
Incorvaia, Cristoforo
Moingeon, Philippe
Frati, Franco
Passalacqua, Giovanni
Rossi, Lucilla
Canonica, Giorgio W.
Source :
Clinical & Molecular Allergy; 2010, Vol. 8, p4-7, 4p
Publication Year :
2010

Abstract

Background: Some studies reported the possible induction of food allergy, caused by neo-sensitization to cross-reacting allergens, during immunotherapy with aeroallergens, while other studies ruled out such possibility. Objectives: The aim of this study was to evaluate the development of neo-sensitization to Pen a 1 (tropomyosin) as well as the appearance of reactions after ingestion of foods containing tropomyosin as a consequence of sublingual mite immunization. Materials and methods: Specific IgE to Tropomyosin (rPen a 1) before and after mite sublingual immunotherapy in 134 subjects were measured. IgE-specific antibodies for mite extract and recombinant allergen Pen a 1 were evaluated using the immunoenzymatic CAP system (Phadia Diagnostics, Milan, Italy). Results: All patients had rPen a 1 IgE negative results before and after mite SLIT and did not show positive shrimp extract skin reactivity and serological rPen a 1 IgE conversion after treatment. More important, no patient showed systemic reactions to crustacean ingestion. Conclusions: Patients did not show neo-sensitization to tropomyosin, a component of the extract (namely mite group 10) administered. An assessment of a patient's possible pre-existing sensitisation to tropomyosin by skin test and/or specific IgE prior to start mite extract immunotherapy is recommended. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
14767961
Volume :
8
Database :
Complementary Index
Journal :
Clinical & Molecular Allergy
Publication Type :
Academic Journal
Accession number :
50262544
Full Text :
https://doi.org/10.1186/1476-7961-8-4